吉田 善紀

Last Update: 2019/06/02 21:41:37

Print

Name(Kanji/Kana/Abecedarium Latinum)
吉田 善紀/ヨシダ ヨシノリ/Yoshida, Yoshinori
Primary Affiliation(Org1/Job title)
Center for iPS Cell Research and Application (CiRA)/Associate Professor
Concurrent Affiliation
Org1 Job title
Center for iPS Cell Research and Application (CiRA) Associate Professor
Academic Organizations You are Affiliated to in Japan
Organization name(Japanese) Organization name(English)
日本循環器学会 The Japanese Circulation Society
日本内科学会 The Japanese Society of Internal Medicine
日本分子生物学会 The Molecular Biology Society of Japan
日本再生医療学会 The Japanese Society for Regenerative Medicine
Academic Organizations Overaseas You are Affiliated to
Organization name Country
International Society for Stem Cell Research
American Heart Association
Heart Rhythm Society
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 京都大学
Academic Resume (Undergraduate School/Majors)
University(Japanese) University(English) Faculty(Japanese) Faculty(English) Major(s)(Japanese) Major(s)(English) Completion Status
京都大学 医学部医学科 卒業
ORCID ID
https://orcid.org/0000-0001-5511-9090
researchmap URL
https://researchmap.jp/7000008886
Research Topics
(Japanese)
iPS細胞由来心筋・血液細胞の臨床応用に向けた研究
(English)
Toward clinical applications of cardiomyocytes and hematopoietic cells derived from pluripotent stem cells
Overview of the research
(Japanese)
当研究室では①再生医療の開発研究、②心疾患、血液疾患の疾患モデル研究・創薬、③分化細胞の成熟制御法の開発、④多能性幹細胞(ES細胞/iPS細胞)の分化能を規定する因子の解明の4つのテーマに取り組んでいます。
(English)
Our lab is using iPS cells to study cardiomyocytes and blood cells with application towards regenerative medicine, drug discovery and disease modeling. 1. Development of myocardial regenerative medicine. 2. Disease modeling using iPS cells. 3. Efficient generation and maturation of cardiomyocytes and blood cells for clinical application. 4. Investigation into mechanisms determining the differentiation capacity of ES/iPS cells.
Fields of research (key words)
Key words(Japanese) Key words(English)
iPS細胞、心筋細胞、再生医療、心不全、血液細胞 iPS cells, cardiomyocytes, regenerative medicine, heart failure, blood cells
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, Ueda T, Gee P, Nishikawa M, Nomura M, Kitaoka F, Takahashi T, Okita K, Yoshida Y, Kaneko S, Hotta A Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, Ueda T, Gee P, Nishikawa M, Nomura M, Kitaoka F, Takahashi T, Okita K, Yoshida Y, Kaneko S, Hotta A Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, Ueda T, Gee P, Nishikawa M, Nomura M, Kitaoka F, Takahashi T, Okita K, Yoshida Y, Kaneko S, Hotta A Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility. Cell Stem Cell, 24, 4, 566-578 Cell Stem Cell, 24, 4, 566-578 Cell Stem Cell, 24, 4, 566-578 2019/04 Refereed English Research paper(scientific journal) Disclose to all
Takaki T, Inagaki A, Chonabayashi K, Inoue K, Miki K, Ohno S, Makiyama T, Horie M, Yoshida Y Takaki T, Inagaki A, Chonabayashi K, Inoue K, Miki K, Ohno S, Makiyama T, Horie M, Yoshida Y Takaki T, Inagaki A, Chonabayashi K, Inoue K, Miki K, Ohno S, Makiyama T, Horie M, Yoshida Y Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients. Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients. Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients. Stem cells international, 2019, 7532657 Stem cells international, 2019, 7532657 Stem cells international, 2019, 7532657 2019/03 Refereed Disclose to all
Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development. Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development. Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development. Physiological reviews, 99, 1, 79-114 Physiological reviews, 99, 1, 79-114 Physiological reviews, 99, 1, 79-114 2019/01 Refereed Disclose to all
Hatani T, Funakoshi S, Deerinck TJ, Bushong EA, Kimura T, Takeshima H, Ellisman MH, Hoshijima M, Yoshida Y Hatani T, Funakoshi S, Deerinck TJ, Bushong EA, Kimura T, Takeshima H, Ellisman MH, Hoshijima M, Yoshida Y Hatani T, Funakoshi S, Deerinck TJ, Bushong EA, Kimura T, Takeshima H, Ellisman MH, Hoshijima M, Yoshida Y Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2. Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2. Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2. Biochemical and biophysical research communications, 505, 4, 1251-1256 Biochemical and biophysical research communications, 505, 4, 1251-1256 Biochemical and biophysical research communications, 505, 4, 1251-1256 2018/11 Refereed Disclose to all
Wuriyanghai Y, Makiyama T, Sasaki K, Kamakura T, Yamamoto Y, Hayano M, Harita T, Nishiuchi S, Chen J, Kohjitani H, Hirose S, Yokoi F, Gao J, Chonabayashi K, Watanabe K, Ohno S, Yoshida Y, Kimura T, Horie M Wuriyanghai Y, Makiyama T, Sasaki K, Kamakura T, Yamamoto Y, Hayano M, Harita T, Nishiuchi S, Chen J, Kohjitani H, Hirose S, Yokoi F, Gao J, Chonabayashi K, Watanabe K, Ohno S, Yoshida Y, Kimura T, Horie M Wuriyanghai Y, Makiyama T, Sasaki K, Kamakura T, Yamamoto Y, Hayano M, Harita T, Nishiuchi S, Chen J, Kohjitani H, Hirose S, Yokoi F, Gao J, Chonabayashi K, Watanabe K, Ohno S, Yoshida Y, Kimura T, Horie M Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation. Heart rhythm, 15, 10, 1566-1574 Heart rhythm, 15, 10, 1566-1574 Heart rhythm, 15, 10, 1566-1574 2018/10 Refereed Disclose to all
Espinoza JL, Elbadry MI, Chonabayashi K, Yoshida Y, Katagiri T, Harada K, Nakagawa N, Zaimoku Y, Imi T, Hassanein HA, Khalifa A Noreldin A, Takenaka K, Akashi K, Hamana H, Kishi H, Akatsuka Y, Nakao S. Espinoza JL, Elbadry MI, Chonabayashi K, Yoshida Y, Katagiri T, Harada K, Nakagawa N, Zaimoku Y, Imi T, Hassanein HA, Khalifa A Noreldin A, Takenaka K, Akashi K, Hamana H, Kishi H, Akatsuka Y, Nakao S. Espinoza JL, Elbadry MI, Chonabayashi K, Yoshida Y, Katagiri T, Harada K, Nakagawa N, Zaimoku Y, Imi T, Hassanein HA, Khalifa A Noreldin A, Takenaka K, Akashi K, Hamana H, Kishi H, Akatsuka Y, Nakao S. Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack. Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack. Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack. Blood Advances, 2, 4, 390-400 Blood Advances, 2, 4, 390-400 Blood Advances, 2, 4, 390-400 2018/02 Refereed Disclose to all
Takeda M, Kanki Y, Masumoto H, Funakoshi S, Hatani T, Fukushima H, Izumi-Taguchi A, Matsui Y, Shimamura T, Yoshida Y, Yamashita JK. Takeda M, Kanki Y, Masumoto H, Funakoshi S, Hatani T, Fukushima H, Izumi-Taguchi A, Matsui Y, Shimamura T, Yoshida Y, Yamashita JK. Takeda M, Kanki Y, Masumoto H, Funakoshi S, Hatani T, Fukushima H, Izumi-Taguchi A, Matsui Y, Shimamura T, Yoshida Y, Yamashita JK. Identification of Cardiomyocyte-Fated Progenitors from Human-Induced Pluripotent Stem Cells Marked with CD82 Identification of Cardiomyocyte-Fated Progenitors from Human-Induced Pluripotent Stem Cells Marked with CD82 Identification of Cardiomyocyte-Fated Progenitors from Human-Induced Pluripotent Stem Cells Marked with CD82 Cell Reports, 22, 2, 546-556 Cell Reports, 22, 2, 546-556 Cell Reports, 22, 2, 546-556 2018/01 Refereed Disclose to all
Hatani T, Miki K, Yoshida Y Hatani T, Miki K, Yoshida Y Hatani T, Miki K, Yoshida Y Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies. Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies. Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies. Methods in molecular biology (Clifton, N.J.), 1816, 79-92 Methods in molecular biology (Clifton, N.J.), 1816, 79-92 Methods in molecular biology (Clifton, N.J.), 1816, 79-92 2018 Refereed Disclose to all
吉田 善紀 吉田 善紀 吉田 善紀 【iPS細胞技術を駆使したがん、感染症のあらたな制御】 疾患iPS細胞 血液疾患の病態解明への応用 【iPS細胞技術を駆使したがん、感染症のあらたな制御】 疾患iPS細胞 血液疾患の病態解明への応用 【iPS細胞技術を駆使したがん、感染症のあらたな制御】 疾患iPS細胞 血液疾患の病態解明への応用 医学のあゆみ, 263, 11-12, 946-950 医学のあゆみ, 263, 11-12, 946-950 医学のあゆみ, 263, 11-12, 946-950 2017/12 Japanese Disclose to all
Yoshida Y*, Yamanaka S Yoshida Y*, Yamanaka S Yoshida Y*, Yamanaka S Induced Pluripotent Stem Cells Ten Years Later: For Cardiac Applications Induced Pluripotent Stem Cells Ten Years Later: For Cardiac Applications Induced Pluripotent Stem Cells Ten Years Later: For Cardiac Applications Circulation Research, 120, 12, 1958-1968 Circulation Research, 120, 12, 1958-1968 Circulation Research, 120, 12, 1958-1968 2017/11 Refereed Disclose to all
梅田 雅之, 吉田 善紀 梅田 雅之, 吉田 善紀 梅田 雅之, 吉田 善紀 iPS細胞と血液分化 iPS細胞と血液分化 iPS細胞と血液分化 臨床免疫・アレルギー科, 68, 3, 321-327 臨床免疫・アレルギー科, 68, 3, 321-327 臨床免疫・アレルギー科, 68, 3, 321-327 2017/09 Japanese Disclose to all
Kawamura M, Miyagawa S, Fukushima S, Saito A, Miki K, Funakoshi S, Yoshida Y, Yamanaka S, Shimizu T, Okano T, Daimon T, Toda T, Sawa Y. Kawamura M, Miyagawa S, Fukushima S, Saito A, Miki K, Funakoshi S, Yoshida Y, Yamanaka S, Shimizu T, Okano T, Daimon T, Toda T, Sawa Y. Kawamura M, Miyagawa S, Fukushima S, Saito A, Miki K, Funakoshi S, Yoshida Y, Yamanaka S, Shimizu T, Okano T, Daimon T, Toda T, Sawa Y. Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model Scientific Reports, 7, 1, 8824 Scientific Reports, 7, 1, 8824 Scientific Reports, 7, 1, 8824 2017/08 Refereed Disclose to all
Nakanishi H, Miki K, Komatsu KR, Umeda M, Mochizuki M, Inagaki A, Yoshida Y, Saito H Nakanishi H, Miki K, Komatsu KR, Umeda M, Mochizuki M, Inagaki A, Yoshida Y, Saito H Nakanishi H, Miki K, Komatsu KR, Umeda M, Mochizuki M, Inagaki A, Yoshida Y, Saito H Monitoring and visualizing microRNA dynamics during live cell differentiation using microRNA-responsive non-viral reporter vectors Monitoring and visualizing microRNA dynamics during live cell differentiation using microRNA-responsive non-viral reporter vectors Monitoring and visualizing microRNA dynamics during live cell differentiation using microRNA-responsive non-viral reporter vectors Biomaterials, 128, 121-135 Biomaterials, 128, 121-135 Biomaterials, 128, 121-135 2017/06 Refereed Disclose to all
Kuang Y, Miki K, Parr CJ, Hayashi K, Takei I, Li J, Iwasaki M, Nakagawa M, Yoshida Y, Saito H Kuang Y, Miki K, Parr CJ, Hayashi K, Takei I, Li J, Iwasaki M, Nakagawa M, Yoshida Y, Saito H Kuang Y, Miki K, Parr CJ, Hayashi K, Takei I, Li J, Iwasaki M, Nakagawa M, Yoshida Y, Saito H Efficient and Selective Removal of Human Pluripotent Stem Cells via Ecto-Alkaline Phosphatase-Mediated Aggregation of Synthetic Peptides Efficient and Selective Removal of Human Pluripotent Stem Cells via Ecto-Alkaline Phosphatase-Mediated Aggregation of Synthetic Peptides Efficient and Selective Removal of Human Pluripotent Stem Cells via Ecto-Alkaline Phosphatase-Mediated Aggregation of Synthetic Peptides Cell Chemical Biology, 24, 6, 685-694 Cell Chemical Biology, 24, 6, 685-694 Cell Chemical Biology, 24, 6, 685-694 2017/06 Refereed Disclose to all
Hayano M, Makiyama T*, Kamakura T, Watanabe H, Sasaki K, Funakoshi S, Wuriyanghai Y, Nishiuchi S, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Yokoi F, Chen J, Baba O, Horie T, Chonabayashi K, Ohno S, Toyoda F, Yoshida Y*, Ono K, Horie M, Kimura T Hayano M, Makiyama T*, Kamakura T, Watanabe H, Sasaki K, Funakoshi S, Wuriyanghai Y, Nishiuchi S, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Yokoi F, Chen J, Baba O, Horie T, Chonabayashi K, Ohno S, Toyoda F, Yoshida Y*, Ono K, Horie M, Kimura T Hayano M, Makiyama T*, Kamakura T, Watanabe H, Sasaki K, Funakoshi S, Wuriyanghai Y, Nishiuchi S, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Yokoi F, Chen J, Baba O, Horie T, Chonabayashi K, Ohno S, Toyoda F, Yoshida Y*, Ono K, Horie M, Kimura T The Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy. The Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy. The Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy. Circulation Journal, 81, 12, 1783-1791 Circulation Journal, 81, 12, 1783-1791 Circulation Journal, 81, 12, 1783-1791 2017/06 Refereed Disclose to all
中村 正裕, 吉田 善紀, 渡辺 亮 中村 正裕, 吉田 善紀, 渡辺 亮 中村 正裕, 吉田 善紀, 渡辺 亮 【日常化するシングルセル遺伝子発現解析】 心筋分化過程を描写するシングルセル遺伝子発現解析 【日常化するシングルセル遺伝子発現解析】 心筋分化過程を描写するシングルセル遺伝子発現解析 【日常化するシングルセル遺伝子発現解析】 心筋分化過程を描写するシングルセル遺伝子発現解析 細胞, 49, 6, 277-280 細胞, 49, 6, 277-280 細胞, 49, 6, 277-280 2017/05 Japanese Disclose to all
Yamamoto Y, Makiyama T*, Harita T, Sasaki K, Wuriyanghai Y, Hayano M, Nishiuchi S, Kohjitani H, Hirose S, Chen J, Yokoi F, Ishikawa T, Ohno S, Chonabayashi K, Motomura H, Yoshida Y*, Horie M, Makita N*, Kimura T Yamamoto Y, Makiyama T*, Harita T, Sasaki K, Wuriyanghai Y, Hayano M, Nishiuchi S, Kohjitani H, Hirose S, Chen J, Yokoi F, Ishikawa T, Ohno S, Chonabayashi K, Motomura H, Yoshida Y*, Horie M, Makita N*, Kimura T Yamamoto Y, Makiyama T*, Harita T, Sasaki K, Wuriyanghai Y, Hayano M, Nishiuchi S, Kohjitani H, Hirose S, Chen J, Yokoi F, Ishikawa T, Ohno S, Chonabayashi K, Motomura H, Yoshida Y*, Horie M, Makita N*, Kimura T Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation Human Molecular Genetics, 26, 9, 1670-1677 Human Molecular Genetics, 26, 9, 1670-1677 Human Molecular Genetics, 26, 9, 1670-1677 2017/05 Refereed Disclose to all
Ueki J, Nakamori M, Nakamura M, Nishikawa M, Yoshida Y, Tanaka A, Morizane A, Kamon M, Araki T, Takahashi MP, Watanabe A, Inagaki N, Sakurai M Ueki J, Nakamori M, Nakamura M, Nishikawa M, Yoshida Y, Tanaka A, Morizane A, Kamon M, Araki T, Takahashi MP, Watanabe A, Inagaki N, Sakurai M Ueki J, Nakamori M, Nakamura M, Nishikawa M, Yoshida Y, Tanaka A, Morizane A, Kamon M, Araki T, Takahashi MP, Watanabe A, Inagaki N, Sakurai M Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability Scientific Reports, 7, 42522 Scientific Reports, 7, 42522 Scientific Reports, 7, 42522 2017/02 Refereed Disclose to all
Chonabayashi K, Yoshida Y, Takaori-Kondo A Chonabayashi K, Yoshida Y, Takaori-Kondo A Chonabayashi K, Yoshida Y, Takaori-Kondo A Reprogramming technology reveals genetic and functional diversity of subclones in myelodysplastic syndromes. Reprogramming technology reveals genetic and functional diversity of subclones in myelodysplastic syndromes. Reprogramming technology reveals genetic and functional diversity of subclones in myelodysplastic syndromes. [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 7, 787-791 [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 7, 787-791 [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 7, 787-791 2017 Refereed Disclose to all
Sasaki K, Makiyama T*, Yoshida Y*, Wuriyanghai Y, Kamakura T, Nishiuchi S, Hayano M, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Chen J, Itoh H, Kawamura M, Ohno S, Takeuchi A, Matsuoka S, Miura M, Sumitomo N, Horie M, Yamanaka S, Kimura T Sasaki K, Makiyama T*, Yoshida Y*, Wuriyanghai Y, Kamakura T, Nishiuchi S, Hayano M, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Chen J, Itoh H, Kawamura M, Ohno S, Takeuchi A, Matsuoka S, Miura M, Sumitomo N, Horie M, Yamanaka S, Kimura T Sasaki K, Makiyama T*, Yoshida Y*, Wuriyanghai Y, Kamakura T, Nishiuchi S, Hayano M, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Chen J, Itoh H, Kawamura M, Ohno S, Takeuchi A, Matsuoka S, Miura M, Sumitomo N, Horie M, Yamanaka S, Kimura T Patient-specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia. Patient-specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia. Patient-specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia. PLoS ONE, 11, 10, e0164795 PLoS ONE, 11, 10, e0164795 PLoS ONE, 11, 10, e0164795 2016/10 Refereed Disclose to all
Nishizawa M, Chonabayashi K, Nomura M, Tanaka A, Nakamura M, Inagaki A, Nishikawa M, Takei I, Oishi A, Tanabe K, Ohnuki M, Yokota H, Koyanagi-Aoi M, Okita K, Watanabe A, Takaori-Kondo A, Yamanaka S, Yoshida Y* Nishizawa M, Chonabayashi K, Nomura M, Tanaka A, Nakamura M, Inagaki A, Nishikawa M, Takei I, Oishi A, Tanabe K, Ohnuki M, Yokota H, Koyanagi-Aoi M, Okita K, Watanabe A, Takaori-Kondo A, Yamanaka S, Yoshida Y* Nishizawa M, Chonabayashi K, Nomura M, Tanaka A, Nakamura M, Inagaki A, Nishikawa M, Takei I, Oishi A, Tanabe K, Ohnuki M, Yokota H, Koyanagi-Aoi M, Okita K, Watanabe A, Takaori-Kondo A, Yamanaka S, Yoshida Y* Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity Cell Stem Cell, 19, 3, 341-354 Cell Stem Cell, 19, 3, 341-354 Cell Stem Cell, 19, 3, 341-354 2016/09 Refereed Disclose to all
Parr CJ, Katayama S, Miki K, Kuang Y, Yoshida Y, Morizane A, Takahashi J, Yamanaka S, Saito H Parr CJ, Katayama S, Miki K, Kuang Y, Yoshida Y, Morizane A, Takahashi J, Yamanaka S, Saito H Parr CJ, Katayama S, Miki K, Kuang Y, Yoshida Y, Morizane A, Takahashi J, Yamanaka S, Saito H MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells. MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells. MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells. Scientific Reports, 6, 32532 Scientific Reports, 6, 32532 Scientific Reports, 6, 32532 2016/09 Refereed Disclose to all
Oceguera-Yanez F, Kim SI, Matsumoto T, Tan GW, Xiang L, Hatani T, Kondo T, Ikeya M, Yoshida Y, Inoue H, Woltjen K Oceguera-Yanez F, Kim SI, Matsumoto T, Tan GW, Xiang L, Hatani T, Kondo T, Ikeya M, Yoshida Y, Inoue H, Woltjen K Oceguera-Yanez F, Kim SI, Matsumoto T, Tan GW, Xiang L, Hatani T, Kondo T, Ikeya M, Yoshida Y, Inoue H, Woltjen K Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives Methods, 101, 43-55 Methods, 101, 43-55 Methods, 101, 43-55 2016/05 Refereed Disclose to all
吉田 善紀 吉田 善紀 吉田 善紀 【再生医学と血管】 iPS細胞を用いた血管再生研究の展望と課題 【再生医学と血管】 iPS細胞を用いた血管再生研究の展望と課題 【再生医学と血管】 iPS細胞を用いた血管再生研究の展望と課題 血管医学, 17, 1, 25-31 血管医学, 17, 1, 25-31 血管医学, 17, 1, 25-31 2016/03 Japanese Disclose to all
Morita Y, Andersen P, Hotta A, Tsukahara Y, Sasagawa N, Hayashida N, Koga C, Nishikawa M, Saga Y, Evans SM, Koshiba-Takeuchi K, Nishinakamura R, Yoshida Y, Kwon C, Takeuchi JK. Morita Y, Andersen P, Hotta A, Tsukahara Y, Sasagawa N, Hayashida N, Koga C, Nishikawa M, Saga Y, Evans SM, Koshiba-Takeuchi K, Nishinakamura R, Yoshida Y, Kwon C, Takeuchi JK. Morita Y, Andersen P, Hotta A, Tsukahara Y, Sasagawa N, Hayashida N, Koga C, Nishikawa M, Saga Y, Evans SM, Koshiba-Takeuchi K, Nishinakamura R, Yoshida Y, Kwon C, Takeuchi JK. Sall1 transiently marks undifferentiated heart precursors and regulates their fate. Sall1 transiently marks undifferentiated heart precursors and regulates their fate. Sall1 transiently marks undifferentiated heart precursors and regulates their fate. Journal of Molecular and Cellular Cardiology, 92, 158-162 Journal of Molecular and Cellular Cardiology, 92, 158-162 Journal of Molecular and Cellular Cardiology, 92, 158-162 2016/03 Refereed Disclose to all
Kawamura T, Miyagawa S, Fukushima S, Maeda A, Kashiyama N, Kawamura A, Miki K, Okita K, Yoshida Y, Shiina T, Ogasawara K, Miyagawa S, Toda K, Okuyama H, Sawa Y. Kawamura T, Miyagawa S, Fukushima S, Maeda A, Kashiyama N, Kawamura A, Miki K, Okita K, Yoshida Y, Shiina T, Ogasawara K, Miyagawa S, Toda K, Okuyama H, Sawa Y. Kawamura T, Miyagawa S, Fukushima S, Maeda A, Kashiyama N, Kawamura A, Miki K, Okita K, Yoshida Y, Shiina T, Ogasawara K, Miyagawa S, Toda K, Okuyama H, Sawa Y. Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates. Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates. Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates. Stem Cell Reports, 6, 3, 312-320 Stem Cell Reports, 6, 3, 312-320 Stem Cell Reports, 6, 3, 312-320 2016/03 Refereed Disclose to all
Yoshida Y*, Yamanaka S. Yoshida Y*, Yamanaka S. Yoshida Y*, Yamanaka S. Understanding Intracellular Signaling Advances Cardiac Reprogramming Technology Toward Clinical Applications. Understanding Intracellular Signaling Advances Cardiac Reprogramming Technology Toward Clinical Applications. Understanding Intracellular Signaling Advances Cardiac Reprogramming Technology Toward Clinical Applications. Circulation Research, 118, 3, 377-378 Circulation Research, 118, 3, 377-378 Circulation Research, 118, 3, 377-378 2016/02 Refereed Disclose to all
Funakoshi S, Miki K, Takaki T, Okubo C, Hatani T, Chonabayashi K, Nishikawa M, Takei I, Oishi A, Narita M, Hoshijima M, Kimura T, Yamanaka S, Yoshida Y* Funakoshi S, Miki K, Takaki T, Okubo C, Hatani T, Chonabayashi K, Nishikawa M, Takei I, Oishi A, Narita M, Hoshijima M, Kimura T, Yamanaka S, Yoshida Y* Funakoshi S, Miki K, Takaki T, Okubo C, Hatani T, Chonabayashi K, Nishikawa M, Takei I, Oishi A, Narita M, Hoshijima M, Kimura T, Yamanaka S, Yoshida Y* Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Scientific Reports, 9, 19111 Scientific Reports, 9, 19111 Scientific Reports, 9, 19111 2016/01 Refereed Disclose to all
舟越 俊介, 山中 伸弥, 吉田 善紀 舟越 俊介, 山中 伸弥, 吉田 善紀 舟越 俊介, 山中 伸弥, 吉田 善紀 日本のパイオニア 日本で開発された細胞 iPS細胞 日本のパイオニア 日本で開発された細胞 iPS細胞 日本のパイオニア 日本で開発された細胞 iPS細胞 循環器専門医, 23, 2, 299-304 循環器専門医, 23, 2, 299-304 循環器専門医, 23, 2, 299-304 2015/09 Japanese Disclose to all
Miki K, Endo K, Takahashi S, Funakoshi S, Takei I, Katayama S, Toyoda T, Kotaka M, Takaki T, Umeda M, Okubo C, Nishikawa M, Oishi A, Narita M, Miyashita I, Asano K, Hayashi K, Osafune K, Yamanaka S, Saito H*, Yoshida Y*. Miki K, Endo K, Takahashi S, Funakoshi S, Takei I, Katayama S, Toyoda T, Kotaka M, Takaki T, Umeda M, Okubo C, Nishikawa M, Oishi A, Narita M, Miyashita I, Asano K, Hayashi K, Osafune K, Yamanaka S, Saito H*, Yoshida Y*. Miki K, Endo K, Takahashi S, Funakoshi S, Takei I, Katayama S, Toyoda T, Kotaka M, Takaki T, Umeda M, Okubo C, Nishikawa M, Oishi A, Narita M, Miyashita I, Asano K, Hayashi K, Osafune K, Yamanaka S, Saito H*, Yoshida Y*. Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches Cell Stem Cell, 16, 6, 699-711 Cell Stem Cell, 16, 6, 699-711 Cell Stem Cell, 16, 6, 699-711 2015/06 Refereed Disclose to all
蝶名林 和久, 吉田 善紀, 高折 晃史 蝶名林 和久, 吉田 善紀, 高折 晃史 蝶名林 和久, 吉田 善紀, 高折 晃史 【iPS細胞を用いた難病研究-臨床病態解明と創薬に向けた研究の最新知見】 (第4章)血液・免疫疾患 リプログラミング技術を用いた骨髄異形成症候群の病態解明と新規治療の可能性 【iPS細胞を用いた難病研究-臨床病態解明と創薬に向けた研究の最新知見】 (第4章)血液・免疫疾患 リプログラミング技術を用いた骨髄異形成症候群の病態解明と新規治療の可能性 【iPS細胞を用いた難病研究-臨床病態解明と創薬に向けた研究の最新知見】 (第4章)血液・免疫疾患 リプログラミング技術を用いた骨髄異形成症候群の病態解明と新規治療の可能性 遺伝子医学MOOK, 27, 147-151 遺伝子医学MOOK, 27, 147-151 遺伝子医学MOOK, 27, 147-151 2015/02 Japanese Disclose to all
中村 正裕, 野村 真樹, 溝曽路 祥孝, 吉田 善紀, 渡辺 亮 中村 正裕, 野村 真樹, 溝曽路 祥孝, 吉田 善紀, 渡辺 亮 中村 正裕, 野村 真樹, 溝曽路 祥孝, 吉田 善紀, 渡辺 亮 【シングルセル生物学】 幹細胞・発生研究におけるシングルセル遺伝子発現解析 【シングルセル生物学】 幹細胞・発生研究におけるシングルセル遺伝子発現解析 【シングルセル生物学】 幹細胞・発生研究におけるシングルセル遺伝子発現解析 実験医学, 33, 1, 15-19 実験医学, 33, 1, 15-19 実験医学, 33, 1, 15-19 2015/01 Japanese Disclose to all
吉田 善紀 吉田 善紀 吉田 善紀 【循環器疾患と再生医療】 ES細胞とiPS細胞 【循環器疾患と再生医療】 ES細胞とiPS細胞 【循環器疾患と再生医療】 ES細胞とiPS細胞 心臓, 46, 12, 1546-1549 心臓, 46, 12, 1546-1549 心臓, 46, 12, 1546-1549 2014/12 Japanese Disclose to all
Tokunaga K, Saitoh N, Goldberg I, Sakamoto C, Yasuda Y, Yoshida Y, Yamanaka S, Nakao M Tokunaga K, Saitoh N, Goldberg I, Sakamoto C, Yasuda Y, Yoshida Y, Yamanaka S, Nakao M Tokunaga K, Saitoh N, Goldberg I, Sakamoto C, Yasuda Y, Yoshida Y, Yamanaka S, Nakao M Computational image analysis of colony and nuclear morphology to evaluate human induced pluripotent stem cells Computational image analysis of colony and nuclear morphology to evaluate human induced pluripotent stem cells Computational image analysis of colony and nuclear morphology to evaluate human induced pluripotent stem cells Scientific Reports, 4, 6996 Scientific Reports, 4, 6996 Scientific Reports, 4, 6996 2014/11 Refereed Disclose to all
吉田 善紀, 山中 伸弥 吉田 善紀, 山中 伸弥 吉田 善紀, 山中 伸弥 【医学・医療のいまがわかるキーワード2014】 再生医学 iPS細胞 【医学・医療のいまがわかるキーワード2014】 再生医学 iPS細胞 【医学・医療のいまがわかるキーワード2014】 再生医学 iPS細胞 医学のあゆみ, 249, 5, 404-405 医学のあゆみ, 249, 5, 404-405 医学のあゆみ, 249, 5, 404-405 2014/05 Japanese Disclose to all
M. Nakagawa; Y. Taniguchi; S. Senda; N. Takizawa; T. Ichisaka; K. Asano; A. Morizane; D. Doi; J. Takahashi; M. Nishizawa; Y. Yoshida; T. Toyoda; K. Osafune; K. Sekiguchi; S. Yamanaka M. Nakagawa; Y. Taniguchi; S. Senda; N. Takizawa; T. Ichisaka; K. Asano; A. Morizane; D. Doi; J. Takahashi; M. Nishizawa; Y. Yoshida; T. Toyoda; K. Osafune; K. Sekiguchi; S. Yamanaka M. Nakagawa; Y. Taniguchi; S. Senda; N. Takizawa; T. Ichisaka; K. Asano; A. Morizane; D. Doi; J. Takahashi; M. Nishizawa; Y. Yoshida; T. Toyoda; K. Osafune; K. Sekiguchi; S. Yamanaka A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells Scientific Reports, 4, 3594 Scientific Reports, 4, 3594 Scientific Reports, 4, 3594 2014/01 Refereed English Disclose to all
K. Miki; Y. Yoshida; S. Yamanaka K. Miki; Y. Yoshida; S. Yamanaka K. Miki; Y. Yoshida; S. Yamanaka Making steady progress on direct cardiac reprogramming toward clinical application Making steady progress on direct cardiac reprogramming toward clinical application Making steady progress on direct cardiac reprogramming toward clinical application Circulation Research, 113, 1, 13-15 Circulation Research, 113, 1, 13-15 Circulation Research, 113, 1, 13-15 2013/06 Refereed English Disclose to all
T. Kamakura; T. Makiyama; K. Sasaki; Y. Yoshida; Y. Wuriyanghai; J. Chen; T. Hattori; S. Ohno; T. Kita; M. Horie; S. Yamanaka; T. Kimura T. Kamakura; T. Makiyama; K. Sasaki; Y. Yoshida; Y. Wuriyanghai; J. Chen; T. Hattori; S. Ohno; T. Kita; M. Horie; S. Yamanaka; T. Kimura T. Kamakura; T. Makiyama; K. Sasaki; Y. Yoshida; Y. Wuriyanghai; J. Chen; T. Hattori; S. Ohno; T. Kita; M. Horie; S. Yamanaka; T. Kimura Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture Circulation Journal, 77, 5, 1307-1314 Circulation Journal, 77, 5, 1307-1314 Circulation Journal, 77, 5, 1307-1314 2013/05 Refereed English Disclose to all
Y. Yoshida; S. Yamanaka Y. Yoshida; S. Yamanaka Y. Yoshida; S. Yamanaka An emerging strategy of gene therapy for cardiac disease An emerging strategy of gene therapy for cardiac disease An emerging strategy of gene therapy for cardiac disease Circulation Research, 111, 9, 1108-1110 Circulation Research, 111, 9, 1108-1110 Circulation Research, 111, 9, 1108-1110 2012/10 Refereed English Disclose to all
Y. Yoshida; S. Yamanaka Y. Yoshida; S. Yamanaka Y. Yoshida; S. Yamanaka Labor pains of new technology: direct cardiac reprogramming. Labor pains of new technology: direct cardiac reprogramming. Labor pains of new technology: direct cardiac reprogramming. Circulation research, 111, 1, 3-4 Circulation research, 111, 1, 3-4 Circulation research, 111, 1, 3-4 2012/06 Refereed English Disclose to all
吉田善紀 吉田善紀 吉田善紀 iPS細胞を用いた遺伝性心疾患の分子病態の解明と創薬研究 iPS細胞を用いた遺伝性心疾患の分子病態の解明と創薬研究 iPS細胞を用いた遺伝性心疾患の分子病態の解明と創薬研究 遺伝子医学MOOK 22: 133-136 遺伝子医学MOOK 22: 133-136 遺伝子医学MOOK 22: 133-136 2012 Refereed Japanese Disclose to all
Y. Yoshida; S. Yamanaka Y. Yoshida; S. Yamanaka Y. Yoshida; S. Yamanaka IPS cells: A source of cardiac regeneration IPS cells: A source of cardiac regeneration IPS cells: A source of cardiac regeneration Journal of Molecular and Cellular Cardiology, 50, 2, 327-332 Journal of Molecular and Cellular Cardiology, 50, 2, 327-332 Journal of Molecular and Cellular Cardiology, 50, 2, 327-332 2011/02 Refereed English Disclose to all
Y. Yoshida; S. Yamanaka Y. Yoshida; S. Yamanaka Y. Yoshida; S. Yamanaka Recent stem cell advances: Induced pluripotent stem cells for disease modeling and stem cell-based regeneration Recent stem cell advances: Induced pluripotent stem cells for disease modeling and stem cell-based regeneration Recent stem cell advances: Induced pluripotent stem cells for disease modeling and stem cell-based regeneration Circulation, 122, 1, 80-87 Circulation, 122, 1, 80-87 Circulation, 122, 1, 80-87 2010/07 Refereed English Disclose to all
Y. Yoshida; T. Morimoto; T. Takaya; T. Kawamura; Y. Sunagawa; H. Wada; M. Fujita; A. Shimatsu; T. Kita; K. Hasegawa Y. Yoshida; T. Morimoto; T. Takaya; T. Kawamura; Y. Sunagawa; H. Wada; M. Fujita; A. Shimatsu; T. Kita; K. Hasegawa Y. Yoshida; T. Morimoto; T. Takaya; T. Kawamura; Y. Sunagawa; H. Wada; M. Fujita; A. Shimatsu; T. Kita; K. Hasegawa Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes Circulation Journal, 74, 1, 156-162 Circulation Journal, 74, 1, 156-162 Circulation Journal, 74, 1, 156-162 2010/01 Refereed English Disclose to all
Y. Nakashima; K. Ono; Y. Yoshida; Y. Kojima; T. Kita; M. Tanaka; T. Kimura Y. Nakashima; K. Ono; Y. Yoshida; Y. Kojima; T. Kita; M. Tanaka; T. Kimura Y. Nakashima; K. Ono; Y. Yoshida; Y. Kojima; T. Kita; M. Tanaka; T. Kimura The search for Nkx2-5-regulated genes using purified embryonic stem cell-derived cardiomyocytes with Nkx2-5 gene targeting The search for Nkx2-5-regulated genes using purified embryonic stem cell-derived cardiomyocytes with Nkx2-5 gene targeting The search for Nkx2-5-regulated genes using purified embryonic stem cell-derived cardiomyocytes with Nkx2-5 gene targeting Biochemical and Biophysical Research Communications, 390, 3, 821-826 Biochemical and Biophysical Research Communications, 390, 3, 821-826 Biochemical and Biophysical Research Communications, 390, 3, 821-826 2009/12/18 Refereed English Disclose to all
Y. Yoshida; K. Takahashi; K. Okita; T. Ichisaka; S. Yamanaka Y. Yoshida; K. Takahashi; K. Okita; T. Ichisaka; S. Yamanaka Y. Yoshida; K. Takahashi; K. Okita; T. Ichisaka; S. Yamanaka Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells Cell Stem Cell, 5, 3, 237-241 Cell Stem Cell, 5, 3, 237-241 Cell Stem Cell, 5, 3, 237-241 2009/09/04 Refereed English Disclose to all
Y. Kojima; K. Ono; K. Inoue; Y. Takagi; K.-i. Kikuta; M. Nishimura; Y. Yoshida; Y. Nakashima; H. Matsumae; Y. Furukawa; N. Mikuni; M. Nobuyoshi; T. Kimura; T. Kita; M. Tanaka Y. Kojima; K. Ono; K. Inoue; Y. Takagi; K.-i. Kikuta; M. Nishimura; Y. Yoshida; Y. Nakashima; H. Matsumae; Y. Furukawa; N. Mikuni; M. Nobuyoshi; T. Kimura; T. Kita; M. Tanaka Y. Kojima; K. Ono; K. Inoue; Y. Takagi; K.-i. Kikuta; M. Nishimura; Y. Yoshida; Y. Nakashima; H. Matsumae; Y. Furukawa; N. Mikuni; M. Nobuyoshi; T. Kimura; T. Kita; M. Tanaka Progranulin expression in advanced human atherosclerotic plaque Progranulin expression in advanced human atherosclerotic plaque Progranulin expression in advanced human atherosclerotic plaque Atherosclerosis, 206, 1, 102-108 Atherosclerosis, 206, 1, 102-108 Atherosclerosis, 206, 1, 102-108 2009/09 Refereed English Disclose to all
H. Matsumae; Y. Yoshida; K. Ono; K. Togi; K. Inoue; Y. Furukawa; Y. Nakashima; Y. Kojima; M. Nobuyoshi; T. Kita; M. Tanaka H. Matsumae; Y. Yoshida; K. Ono; K. Togi; K. Inoue; Y. Furukawa; Y. Nakashima; Y. Kojima; M. Nobuyoshi; T. Kita; M. Tanaka H. Matsumae; Y. Yoshida; K. Ono; K. Togi; K. Inoue; Y. Furukawa; Y. Nakashima; Y. Kojima; M. Nobuyoshi; T. Kita; M. Tanaka CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 6, 1077-1083 Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 6, 1077-1083 Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 6, 1077-1083 2008 Refereed English Disclose to all
Y. Yoshida; K. Togi; H. Matsumae; Y. Nakashima; Y. Kojima; H. Yamamoto; K. Ono; T. Nakamura; T. Kita; M. Tanaka Y. Yoshida; K. Togi; H. Matsumae; Y. Nakashima; Y. Kojima; H. Yamamoto; K. Ono; T. Nakamura; T. Kita; M. Tanaka Y. Yoshida; K. Togi; H. Matsumae; Y. Nakashima; Y. Kojima; H. Yamamoto; K. Ono; T. Nakamura; T. Kita; M. Tanaka CCN1 protects cardiac myocytes from oxidative stress via β1 integrin-Akt pathway CCN1 protects cardiac myocytes from oxidative stress via β1 integrin-Akt pathway CCN1 protects cardiac myocytes from oxidative stress via β1 integrin-Akt pathway Biochemical and Biophysical Research Communications, 355, 3, 611-618 Biochemical and Biophysical Research Communications, 355, 3, 611-618 Biochemical and Biophysical Research Communications, 355, 3, 611-618 2007 Refereed English Disclose to all
K. Togi; Y. Yoshida; H. Matsumae; Y. Nakashima; T. Kita; M. Tanaka K. Togi; Y. Yoshida; H. Matsumae; Y. Nakashima; T. Kita; M. Tanaka K. Togi; Y. Yoshida; H. Matsumae; Y. Nakashima; T. Kita; M. Tanaka Essential role of Hand2 in interventricular septum formation and trabeculation during cardiac development Essential role of Hand2 in interventricular septum formation and trabeculation during cardiac development Essential role of Hand2 in interventricular septum formation and trabeculation during cardiac development Biochemical and Biophysical Research Communications, 343, 1, 144-151 Biochemical and Biophysical Research Communications, 343, 1, 144-151 Biochemical and Biophysical Research Communications, 343, 1, 144-151 2006 Refereed English Disclose to all
T. Kawamoto; K. Togi; R. Yamauchi; Y. Yoshida; Y. Nakashima; T. Kita; M. Tanaka T. Kawamoto; K. Togi; R. Yamauchi; Y. Yoshida; Y. Nakashima; T. Kita; M. Tanaka T. Kawamoto; K. Togi; R. Yamauchi; Y. Yoshida; Y. Nakashima; T. Kita; M. Tanaka Endothelin-1 activates Homer 1a expression via mitogen-activated protein kinase in cardiac myocytes Endothelin-1 activates Homer 1a expression via mitogen-activated protein kinase in cardiac myocytes Endothelin-1 activates Homer 1a expression via mitogen-activated protein kinase in cardiac myocytes International Journal of Molecular Medicine, 18, 1, 193-196 International Journal of Molecular Medicine, 18, 1, 193-196 International Journal of Molecular Medicine, 18, 1, 193-196 2006 Refereed English Disclose to all
K. Togi; T. Kawamoto; R. Yamauchi; Y. Yoshida; T. Kita; M. Tanaka K. Togi; T. Kawamoto; R. Yamauchi; Y. Yoshida; T. Kita; M. Tanaka K. Togi; T. Kawamoto; R. Yamauchi; Y. Yoshida; T. Kita; M. Tanaka Role of Hand1/eHAND in the dorso-ventral patterning and interventricular septum formation in the embryonic heart Role of Hand1/eHAND in the dorso-ventral patterning and interventricular septum formation in the embryonic heart Role of Hand1/eHAND in the dorso-ventral patterning and interventricular septum formation in the embryonic heart Molecular and Cellular Biology, 24, 11, 4627-4635 Molecular and Cellular Biology, 24, 11, 4627-4635 Molecular and Cellular Biology, 24, 11, 4627-4635 2004 Refereed English Disclose to all
S.-J. Park; S.-W. Park; M.-K. Hong; C.W. Lee; J.-H. Lee; J.-J. Kim; Y.S. Jang; E.-K. Shin; Y. Yoshida; T. Tamura; T. Kimura; M. Nobuyoshi S.-J. Park; S.-W. Park; M.-K. Hong; C.W. Lee; J.-H. Lee; J.-J. Kim; Y.S. Jang; E.-K. Shin; Y. Yoshida; T. Tamura; T. Kimura; M. Nobuyoshi S.-J. Park; S.-W. Park; M.-K. Hong; C.W. Lee; J.-H. Lee; J.-J. Kim; Y.S. Jang; E.-K. Shin; Y. Yoshida; T. Tamura; T. Kimura; M. Nobuyoshi Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function American Journal of Cardiology, 91, 1, 12-16 American Journal of Cardiology, 91, 1, 12-16 American Journal of Cardiology, 91, 1, 12-16 2003 Refereed English Disclose to all
T. Kimura; K. Abe; S. Shizuta; K. Odashiro; Y. Yoshida; K. Sakai; K. Kaitani; K. Inoue; Y. Nakagawa; H. Yokoi; M. Iwabuchi; N. Hamasaki; H. Nosaka; M. Nobuyoshi T. Kimura; K. Abe; S. Shizuta; K. Odashiro; Y. Yoshida; K. Sakai; K. Kaitani; K. Inoue; Y. Nakagawa; H. Yokoi; M. Iwabuchi; N. Hamasaki; H. Nosaka; M. Nobuyoshi T. Kimura; K. Abe; S. Shizuta; K. Odashiro; Y. Yoshida; K. Sakai; K. Kaitani; K. Inoue; Y. Nakagawa; H. Yokoi; M. Iwabuchi; N. Hamasaki; H. Nosaka; M. Nobuyoshi Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries Circulation, 105, 25, 2986-2991 Circulation, 105, 25, 2986-2991 Circulation, 105, 25, 2986-2991 2002 Refereed English Disclose to all

  • <<
  • >>
Title language:
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
若手研究(B) Representative CCN1の心臓における機能解析と新しい心疾患治療の開発 2007/04/01-2009/03/31
若手研究(B) Representative 再生医療を目的とした多能性幹細胞によるin vivo心筋分化誘導法の開発 2012-2013
若手研究(B) Representative 再生医療を目的とした多能性幹細胞によるin vivo心筋分化誘導法の開発 2012/04/01-2014/03/31
基盤研究(B) Representative 多能性幹細胞由来心筋細胞の細胞周期制御のための統合的アプローチ (平成29年度分) 2017/04/01-2018/03/31
基盤研究(B) Representative 多能性幹細胞由来心筋細胞の細胞周期制御のための統合的アプローチ (平成30年度分) 2018/04/01-2019/03/31
基盤研究(B) Representative 多能性幹細胞由来心筋細胞の細胞周期制御のための統合的アプローチ (平成30年度分) 2018/04/01-2019/03/31
Faculty management (title, position)
Title Period
共通機器管理運営委員会1号委員 -
エネルギー管理要員 -
安全衛生委員会1号委員、委員長 2016/04/01-